Shanghai Henlius Biotech Statistics
Total Valuation
HKG:2696 has a market cap or net worth of HKD 42.15 billion. The enterprise value is 45.21 billion.
| Market Cap | 42.15B |
| Enterprise Value | 45.21B |
Important Dates
The next estimated earnings date is Tuesday, May 26, 2026.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2696 has 543.49 million shares outstanding. The number of shares has increased by 0.45% in one year.
| Current Share Class | 346.07M |
| Shares Outstanding | 543.49M |
| Shares Change (YoY) | +0.45% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 16.12% |
| Float | 137.57M |
Valuation Ratios
The trailing PE ratio is 46.15 and the forward PE ratio is 29.47.
| PE Ratio | 46.15 |
| Forward PE | 29.47 |
| PS Ratio | 5.68 |
| PB Ratio | 9.56 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 49.13 |
| EV / Sales | 6.09 |
| EV / EBITDA | 36.52 |
| EV / EBIT | 49.72 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.91.
| Current Ratio | 0.71 |
| Quick Ratio | 0.54 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 3.23 |
| Debt / FCF | n/a |
| Interest Coverage | 7.97 |
Financial Efficiency
Return on equity (ROE) is 23.72% and return on invested capital (ROIC) is 12.17%.
| Return on Equity (ROE) | 23.72% |
| Return on Assets (ROA) | 4.45% |
| Return on Invested Capital (ROIC) | 12.17% |
| Return on Capital Employed (ROCE) | 11.01% |
| Weighted Average Cost of Capital (WACC) | 6.64% |
| Revenue Per Employee | 1.97M |
| Profits Per Employee | 244,641 |
| Employee Count | 3,762 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.51 |
Taxes
| Income Tax | -17.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +104.89% in the last 52 weeks. The beta is 0.51, so HKG:2696's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +104.89% |
| 50-Day Moving Average | 72.43 |
| 200-Day Moving Average | 69.45 |
| Relative Strength Index (RSI) | 50.80 |
| Average Volume (20 Days) | 1,339,262 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2696 had revenue of HKD 7.42 billion and earned 920.34 million in profits. Earnings per share was 1.68.
| Revenue | 7.42B |
| Gross Profit | 5.55B |
| Operating Income | 909.30M |
| Pretax Income | 903.29M |
| Net Income | 920.34M |
| EBITDA | 1.24B |
| EBIT | 909.30M |
| Earnings Per Share (EPS) | 1.68 |
Balance Sheet
The company has 938.37 million in cash and 4.00 billion in debt, giving a net cash position of -3.06 billion or -5.64 per share.
| Cash & Cash Equivalents | 938.37M |
| Total Debt | 4.00B |
| Net Cash | -3.06B |
| Net Cash Per Share | -5.64 |
| Equity (Book Value) | 4.41B |
| Book Value Per Share | 8.11 |
| Working Capital | -1.62B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 338.48M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 74.77%, with operating and profit margins of 12.26% and 12.41%.
| Gross Margin | 74.77% |
| Operating Margin | 12.26% |
| Pretax Margin | 12.18% |
| Profit Margin | 12.41% |
| EBITDA Margin | 16.69% |
| EBIT Margin | 12.26% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2696 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.45% |
| Shareholder Yield | -0.45% |
| Earnings Yield | 2.18% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |